Pfizer (PFE) Stock Forecast for 2028. Pfe Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Pfizer Inc. (PFE) Stock Forecast for 2028. Pfe Shares Prediction

Updated: April 24, 2024 (09:40)

Sector: Healthcare

The share price of Pfizer Inc. (PFE) now

What analysts predict: $31.1
52-week High/Low: $38.81 / $25.23

50/200 Day Moving Average: $27.08 / $30.69

This figure corresponds to the Average Price over the previous 50/200 days. For Pfizer stocks, the 50-day moving average is the resistance level today.

For Pfizer stocks, the 200-day moving average is the resistance level today.

Are you interested in Pfizer Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pfizer stock price in 2028. How much will one Pfizer share be worth in 2028? Is it worth taking profit / loss on PFE stock now or waiting? What are analysts' forecasts for Pfizer stock?

We forecast Pfizer stock performance using neural networks based on historical data on PFE stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Pfizer Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Pfizer analysts is $31.1. Today 200 Day Moving Average is the resistance level (30.69 $). 50 Day Moving Average is the support level (27.08 $).




Historical and forecast chart of Pfizer Inc. stock

The chart below shows the historical price of Pfizer stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the PFE stock price can be found in the table below.


Sell or Buy Pfizer (PFE) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the PFE stock market. Experts share their opinions on what to expect.

The Future Brightens: Bold Predictions for PFE Stock in 2028

As we navigate through the intricate financial landscapes of the healthcare sector, predicting the trajectory of Pfizer Inc. (NYSE:PFE) stocks becomes a captivating endeavor. With a rich history spanning over 175 years, Pfizer has established itself as a towering presence in the “big pharma” realm, recently capturing global attention through its instrumental role in combating the COVID-19 pandemic. The critical question looms: how accurately can PFE stock rates be predicted for the year 2028?

Forecasting the future of PFE stocks, especially for a horizon as distant as 2028, involves a meticulous analysis of multiple variables. The celebrated 6.19% dividend yield FY2024 estimate for Pfizer serves as a testament to a business on the verge of revival. Despite a temporary setback attributed to declining sales of COVID-19 related drugs, the company’s relentless pursuit of innovation, underscored by its strong product pipeline and the acquisition of leaders in antibody-drug conjugate (ADC) technology like Seagen, primes it for substantial growth.

Events and Factors Influencing PFE Stocks in 2028

Looking ahead to 2028, several pivotal events and factors will steer the course of PFE stocks. Key among these is the company’s ability to navigate the patent cliff facing some of its drugs. The dynamism of Pfizer’s diverse pipeline, rich in potential blockbusters, stands poised to not only compensate but significantly propel growth. Further, the company’s renowned commercialization and scientific expertise are expected to catalyze the development and marketing of groundbreaking therapies.

The prevailing sentiment suggests an optimistic PFE stock forecast, with projections indicating robust growth potential. Conservative estimates hint at a growth trajectory that could see stock prices appreciating by 50.2% by the end of 2025, setting a precedent for the years leading up to 2028. However, accurately pinpointing exact rates entails considering unforeseen market shifts, regulatory challenges, and global healthcare dynamics.

In conclusion, Pfizer’s strategic decisions to expand its portfolio, the commercial success of its product pipeline, and its skill at overcoming patent expirations will have a significant impact on the evolution of PFE stock rates by 2028. While the full extent of PFE stock appreciation remains shrouded in the complexity of future events, the fundamentals signal a compelling case for both growth and resilience. Thus, for investors pondering whether PFE stock is a buy or sell, a discerning look into the future paints a promising picture of potential ascent.

Pfizer (PFE) Forecast for 2028

Month Target Pes. Opt. Vol., %
Jan 36.71 36.05 38.00 5.13 %
Feb 37.73 35.73 39.50 9.54 %
Mar 37.15 35.28 38.79 9.05 %
Apr 40.03 38.88 42.05 7.54 %
May 40.28 37.74 42.71 11.63 %
Jun 42.39 40.10 44.45 9.78 %
Jul 46.12 42.89 48.32 11.25 %
Aug 43.88 41.16 44.83 8.19 %
Sep 42.54 40.09 43.65 8.16 %
Oct 41.12 39.12 42.90 8.80 %
Nov 38.31 36.24 39.69 8.69 %
Dec 38.79 37.33 40.99 8.94 %

Pfizer information and performance

Pfizer Address

235 E 42ND ST, NEW YORK, NY, US

Market Capitalization: 148 698 300 000 $

Market capitalization of the Pfizer Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of PFE shares in the company outstanding by the market price of one share.

EBITDA: 11 517 000 000 $

EBITDA of Pfizer is earnings before interest, income tax and depreciation of assets.

PE Ratio: 70.97

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.256

Price/earnings to growth

DPS: 1.64

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.064

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.37

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.764
Quarterly Revenue Growth YOY: -0.413
Trailing PE: 70.97

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.67

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.498

Enterprise Value (EV) /Revenue

EV To EBITDA: 21.41

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 5662540000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Pfizer price target for 2028 by month


Target values for the price of one Pfizer share for Jan 2028.

The weighted average target price per Pfizer share in Jan 2028 is: 36.71.
In Jan, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 5.130% volatility is expected.
Pessimistic target level: 36.05
Optimistic target level: 38.00

Target values for the price of one Pfizer share for Feb 2028.

The weighted average target price per Pfizer share in Feb 2028 is: 37.73.
In Feb, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 9.543% volatility is expected.
Pessimistic target level: 35.73
Optimistic target level: 39.50

Target values for the price of one Pfizer share for Mar 2028.

The weighted average target price per Pfizer share in Mar 2028 is: 37.15.
In Mar, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 9.051% volatility is expected.
Pessimistic target level: 35.28
Optimistic target level: 38.79

Target values for the price of one Pfizer share for Apr 2028.

The weighted average target price per Pfizer share in Apr 2028 is: 40.03.
In Apr, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 7.540% volatility is expected.
Pessimistic target level: 38.88
Optimistic target level: 42.05

Target values for the price of one Pfizer share for May 2028.

The weighted average target price per Pfizer share in May 2028 is: 40.28.
In May, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 11.629% volatility is expected.
Pessimistic target level: 37.74
Optimistic target level: 42.71

Target values for the price of one Pfizer share for Jun 2028.

The weighted average target price per Pfizer share in Jun 2028 is: 42.39.
In Jun, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 9.785% volatility is expected.
Pessimistic target level: 40.10
Optimistic target level: 44.45

Target values for the price of one Pfizer share for Jul 2028.

The weighted average target price per Pfizer share in Jul 2028 is: 46.12.
In Jul, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 11.253% volatility is expected.
Pessimistic target level: 42.89
Optimistic target level: 48.32

Target values for the price of one Pfizer share for Aug 2028.

The weighted average target price per Pfizer share in Aug 2028 is: 43.88.
In Aug, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.193% volatility is expected.
Pessimistic target level: 41.16
Optimistic target level: 44.83

Target values for the price of one Pfizer share for Sep 2028.

The weighted average target price per Pfizer share in Sep 2028 is: 42.54.
In Sep, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.157% volatility is expected.
Pessimistic target level: 40.09
Optimistic target level: 43.65

Target values for the price of one Pfizer share for Oct 2028.

The weighted average target price per Pfizer share in Oct 2028 is: 41.12.
In Oct, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.800% volatility is expected.
Pessimistic target level: 39.12
Optimistic target level: 42.90

Target values for the price of one Pfizer share for Nov 2028.

The weighted average target price per Pfizer share in Nov 2028 is: 38.31.
In Nov, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.687% volatility is expected.
Pessimistic target level: 36.24
Optimistic target level: 39.69

Target values for the price of one Pfizer share for Dec 2028.

The weighted average target price per Pfizer share in Dec 2028 is: 38.79.
In Dec, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.943% volatility is expected.
Pessimistic target level: 37.33
Optimistic target level: 40.99



Pfizer (PFE) stock dividend

Pfizer last paid dividends on 01/25/2024. The next scheduled payment will be on 03/01/2024. The amount of dividends is $1.64 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.